| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
(E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid manufacturers
- CK2/PIM1-IN-1
-
- $1980.00
-
2026-04-21
- CAS:292640-28-9
- Purity:
- Supply Ability: 10g
- CK2/PIM1-IN-1
-
- $1980.00
-
2025-07-28
- CAS:292640-28-9
- Purity:
- Supply Ability: 10g
|
| | (E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid Basic information |
| | (E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid Chemical Properties |
| density | 1.60±0.1 g/cm3(Predicted) | | pka | 3.63±0.36(Predicted) |
| | (E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid Usage And Synthesis |
| Uses | CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1]. | | IC 50 | CK2: 3.787 μM (IC50); PIM1: 4.327 μM (IC50) | | References | [1] Mustapha Haddach, et al. Rhodanines and related heterocycles as kinase inhibitors. WO2010148351A1. |
| | (E)-2-(5-((4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid Preparation Products And Raw materials |
|